(MedPage Today) — Use of Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) was associated with significantly higher rates of malignancies compared with biologic agents, data from a large German registry indicated.
Based on more than…
Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/116297
Author :
Publish date : 2025-06-27 20:11:00
Copyright for syndicated content belongs to the linked Source.
